Source: Taiwantrade | Updated: 25 January 2013
TTY Biopharm announced a new factory in China in November last year in a bid to expand in the regional market. The US$100m facility is planned for the production of anti-cancer drug injections.
The company also recently implemented a new facility in Chungli, Taiwan to produce anti-cancer injection. The Chungli facility is planned to begin large volume shipments.
The company has been reported to estimate the facility’s yearly production volume to reach 800,000 to one million shots in 2013.